Batch BeaconUK recalls and safety alerts

Medicines recallMHRA

Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules recalled over a strength or dose problem

Wrong strength or doseMedium riskClass 3

Accord Healthcare Ltd is recalling various batches after retesting showed out of specification results. The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.

Check your product

Only products that match these details are covered. Have your pack in front of you.

183 identifiers listed for this notice.

  • Product 1 28

    Batch codePrinted on the pack, often next to the date mark. It may start with L or LOT.
    • 1110078
    • 1111874
    • 1200540
    • 1203856
    • 1207106
    • 1300367
    • 1300368
    • 1308974
    • 1308975
    • 1203283
    • 1203896
    • 1207494
    • 1208784
    • 1208785
    • 1307499
    • 1309668
    • 1110084
    • 1111119
    • 1200055
    • 1208724
    • 1309624
    • 1309625
    • 1309685
    • 1110101
    • 1111708
    • 1203171
    • 1204488
    • 1205675
    • 1207018
    • 1307133
    • 1309726
    • 1111748
    • 1200173
    • 1200600
    • 1200601
    • 1206867
    • 1300717
    • 1308067
    • 1401176
    • 1111226
    • 1203290
    • 1206825
    • 1208609
    • 1301062
    • 1301063
    • 1307545
    • 1309767
    • 1309768
    • 1111229
    • 1206820
    • 1209117
    • 1210645
    • 1302718
    • 1302719
    Product licenceThe PL number on the carton.
    • PL 20075/1173
    • PL 20075/1174
    • PL 20075/1175
    • PL 20075/1176
    • PL 20075/1177
    • PL 20075/1178
    • PL 20075/1179
    ExpiryOn the carton, blister or label.
    • Jul 2024
    • Aug 2024
    • Oct 2024
    • Mar 2025
    • Jun 2025
    • Sep 2024
    • Oct 2025
    • Jul 2026
    • Aug 2026
    • Jul 2025
    • Jun 2026
    • Sep 2026
    • Apr 2025
    • Dec 2025
    • Nov 2026
    • Feb 2025
    • May 2025
    • Sep 2025
    • Nov 2025
    • Jan 2026
    First distributedOn the product, its label or its packaging.
    • 08 Nov 2021
    • 15 Dec 2021
    • 15 Mar 2022
    • 21 Jun 2022
    • 24 Oct 2022
    • 01 Mar 2023
    • 02 May 2023
    • 19 Jan 2024
    • 19 Feb 2024
    • 16 Jun 2022
    • 08 Sep 2022
    • 31 Oct 2022
    • 17 Jan 2023
    • 28 Mar 2023
    • 15 Dec 2023
    • 07 Mar 2024
    • 19 Nov 2021
    • 11 Jan 2022
    • 11 Feb 2022
    • 23 Jan 2023
    • 29 Jan 2024
    • 28 Mar 2024
    • 08 Mar 2024
    • 17 Nov 2021
    • 25 Jan 2022
    • 15 Jun 2022
    • 25 Jul 2022
    • 01 Sep 2022
    • 20 Sep 2022
    • 13 Sep 2023
    • 08 Feb 2024
    • 10 Dec 2021
    • 07 Mar 2022
    • 17 Oct 2022
    • 19 Apr 2022
    • 16 Jan 2023
    • 31 Mar 2023
    • 23 Oct 2023
    • 13 Mar 2024
    • 13 Dec 2021
    • 03 Oct 2022
    • 30 Dec 2022
    • 09 Mar 2023
    • 17 Jul 2023
    • 06 Nov 2023
    • 19 Mar 2024
    • 09 Feb 2024
    • 13 Jan 2022
    • 29 Sep 2022
    • 09 Oct 2023
    • 12 Jun 2023
  • Product 2 7

    Batch code
    • 1111687
    • 1203285
    • 1207790
    • 1210683
    • 1304125
    • 1307898
    • 1111061
    • 1200640
    • 1300503
    • 1307890
    • 1111692
    • 1200641
    • 1207151
    • 1306982
    • 1307214
    • 1200643
    • 1207152
    • 1300507
    • 1307251
    Expiry
    • Aug 2024
    • Mar 2025
    • Jun 2025
    • Sep 2025
    • Apr 2026
    • Jul 2026
    • Jul 2024
    • Oct 2025
    • Oct 2024
    • May 2025
    • Jun 2026
    • Dec 2024
    • Nov 2025
    First distributed
    • 30 Dec 2021
    • 20 Jun 2022
    • 07 Nov 2022
    • 16 Jan 2023
    • 13 Jul 2023
    • 08 Nov 2023
    • 20 Dec 2021
    • 21 Jun 2022
    • 02 Mar 2023
    • 08 Mar 2024
    • 14 Dec 2021
    • 04 Ap 2022
    • 23 Dec 2022
    • 05 Apr 2024
    • 29 Jan 2024
    • 30 May 2022
    • 03 Oct 2022
    • 06 Mar 2023
    • 22 Mar 2024

What to do now

Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules has been recalled because test results for the affected batches were outside the approved limits for strength or how the medicine dissolves.

  1. Keep taking your medicine unless a healthcare professional tells you otherwise.
  2. Check the batch number and expiry date on your pack against the list on this page.
  3. If it matches, your pharmacist can swap it or arrange an alternative.
  4. Report suspected side effects to the MHRA Yellow Card scheme.

Why it matters. A medicine that is weaker than stated may not control the condition it treats; one that is stronger may cause side effects.

Symptoms and when to get help

Look out for

  • a side effect you have not had before
  • your condition not being controlled as well as usual

Get help urgently

  • signs of a severe allergic reaction, such as swelling of the face or throat or difficulty breathing — call 999
  • if you feel unwell and are worried, speak to a pharmacist, your GP or NHS 111

This is general information based on NHS public guidance, not medical advice. In an emergency call 999. For urgent advice use NHS 111 (NHS 24 on 111 in Scotland) or, in Northern Ireland, your GP or out-of-hours service.

Replacements and prescriptions

The MHRA notice tells pharmacies and healthcare professionals what to do. Patients should keep taking their medicine and ask a pharmacist before stopping.

An affected pack bought over the counter can be returned to where you bought it.

From the official notice

Published by the Medicines and Healthcare products Regulatory Agency (EL(24)A/25). Quoted as issued.

Summary

Accord Healthcare Ltd is recalling various batches after retesting showed out of specification results. The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.

The risk

MDR number MDR 113-05/24 Company name

Advice for healthcare professionals

Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

No further action is required by patients as this recall is being undertaken at a Pharmacy and Wholesaler level as a precautionary measure. Patients should continue to take medicines from these batches as prescribed by your healthcare professional.

Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .

Advice for patients

No further action is required by patients as this recall is being undertaken at a Pharmacy and Wholesaler level as a precautionary measure. Patients should continue to take medicines from these batches as prescribed by your healthcare professional.

Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .

Open the MHRA notice

Questions

Why has Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules been recalled?

Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules has been recalled because test results for the affected batches were outside the approved limits for strength or how the medicine dissolves. A medicine that is weaker than stated may not control the condition it treats; one that is stronger may cause side effects.

How do I know if my medicine is affected?

Compare the batch code, product licence, expiry and date code on your pack with the details listed under “Check your product” on this page. Only items that match are covered by the notice.

What should I do now?

Keep taking your medicine unless a healthcare professional tells you otherwise. Check the batch number and expiry date on your pack against the list on this page.

Do I need a new prescription?

The MHRA notice tells pharmacies and healthcare professionals what to do. Patients should keep taking their medicine and ask a pharmacist before stopping. An affected pack bought over the counter can be returned to where you bought it.

Related notices